Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandru Olaru

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|October 4, 2007
Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cellsJohn M Abraham, Fumiaki Sato, Yulan Cheng, et al.
Plos One|June 26, 2008
Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapyJohn M Abraham, Yulan Cheng, James P Hamilton, et al.
Cancer Research|May 3, 2008
Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinomaTetsuo Ito, Yutaka Shimada, Takatsugu Kan, et al.
International Journal of Cancer|August 12, 2009
Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinomaTadayuki Akagi, Tetsuo Ito, Motohiro Kato, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progressionZhe Jin, James P Hamilton, Jian Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancerZhe Jin, Alexandru Olaru, Jian Yang, et al.
International Journal of Cancer|August 30, 2008
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsZhe Jin, Yulan Cheng, Alexandru Olaru, et al.
Plos One|April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical featuresFumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Science (New York, N.Y.)|April 6, 2002
Genomic instability in mice lacking histone H2AXArkady Celeste, Simone Petersen, Peter J Romanienko, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|October 4, 2007
Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cellsJohn M Abraham, Fumiaki Sato, Yulan Cheng, et al.
Plos One|June 26, 2008
Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapyJohn M Abraham, Yulan Cheng, James P Hamilton, et al.
Cancer Research|May 3, 2008
Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinomaTetsuo Ito, Yutaka Shimada, Takatsugu Kan, et al.
International Journal of Cancer|August 12, 2009
Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinomaTadayuki Akagi, Tetsuo Ito, Motohiro Kato, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progressionZhe Jin, James P Hamilton, Jian Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancerZhe Jin, Alexandru Olaru, Jian Yang, et al.
International Journal of Cancer|August 30, 2008
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsZhe Jin, Yulan Cheng, Alexandru Olaru, et al.
Plos One|April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical featuresFumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Science (New York, N.Y.)|April 6, 2002
Genomic instability in mice lacking histone H2AXArkady Celeste, Simone Petersen, Peter J Romanienko, et al.
Pageof 2